Nova Wealth Management »

Theravance Biopharma shares owned by Nova Wealth Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Nova Wealth Management from 13F filings

Historical chart of Nova Wealth Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Nova Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Nova Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $786 42 18.71
2025-09-30 $612 42 14.60
2025-06-30 $462 42 11.02
2025-03-31 $375 42 8.93
2024-12-31 $395 42 9.40

More positions owned by Nova Wealth Management

Invesco S&p 500 Momentum Etf Etf (SPMO)
Ishares Russell Top 200 Growth Etf Etf (IWY)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
American Century U.s. Quality Growth Etf Etf (QGRO)
Nvidia Corporation Stock (NVDA)
Ishares S&p 100 Etf Etf (OEF)
Invesco S&p Smallcap Momentum Etf Etf (XSMO)
Ft Vest U.s. Equity Deep Buffer Etf - July Etf (DJUL)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Invesco Rafi Strategic Us Etf Etf (IUS)
Defiance Quantum Etf Etf (QTUM)
Vanguard S&p 500 Etf Etf (VOO)
Fidelity Msci Information Technology Index Etf Etf (FTEC)
Sofi Select 500 Etf Etf (SFY)
Ishares U.s. Technology Etf Etf (IYW)

View all positions for Nova Wealth Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Oasis Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
UBS Group

View all funds holding Theravance Biopharma